De rm ato logy, H yogo Coll ege of Medi cin e, H yogo, j apa n We have studied the possible involvement of nitric oxide (NO) in the contact hypersensitivity reaction . A biphasic response of ear swelling was observed at 2 h (early phase) and 24 h (late phase) after application of the antigen to picryl chloride (PCI)-sensiti zed CBA!] nllce. Intravenous injection of NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), at the tiIne of PCI challenge, inhibited in a concentrationdependent fashion the antigen-induced contact hypersensitivity reaction. Low-dose (1 mg!kg) L-NAME inhibited the early-phase re action but not the latephase reaction. High-dose (250 mg/kg) L -NAME inhibited both early-and late-phase reactions. D-NAME (enantiomer ofL-NAME) did not inhibit the antigen-induced ear swelling. High-dose (250 mg/kg) A rece n t exciting find in g rega rdin g cellula r signa lin g is that th e en d othe lium-de ri ved relaxing facto r is actually nitri c oxide (NO) . NO is sy n th es izcd fi'o m t h e amino ac id L-arginin e (Arg) by the cnzym e NO synth ase (NOS) (Bredt and Sn ydcr , 1990). T h e fi'ce radic al NO . is synth cs ized in mammalian sys tems su c h as iml1lunc , cardiovascular, and central nervous systems , w h ere NO acts as a signaling or cytotox ic mo lecu le. NO is ge n e ra ted fi'om t he ox idation of the terminal g u an idin o nitrogen atolll of L-Arg b y the NADPH-d e p e nd e n t NOS. At least two types of NOS ha ve bee n identified: co n stituti ve NOS (cNOS), w hi c h is Ca 2 + -depend e n t, has been found in th e e nd oth e li al ce lls and in th e bra in . Indu cibl e NOS (iNOS), w hi c h is Ca 2 + -ind e pend c n t, ha s becn fo u nd ill activa ted ma c rop ha ges a nd polymorphonuclear ce ll s. Both e n zym es are in hibite d ill lIillo and ill lI it m by seve ral L-Arg analogs, in c ludin g NG-n itro -arginin e methyl ester (L-NAME) (Bredt and Sn yder, 1990).
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The contact h ype rsen siti vity reaction (C HR) in vo lves va ri ous imm unocompetent cell s and m ed iato rs (Go cin ski and T igelaar, 1990). During the ea rl y phase fo ll owing a n tige n c h all e n ge, ma st cell-d erived mediators su c h as hi sta min e a nd se rotonin indu ce vas odila ti o n and in c rease permeability of bl ood vesse ls arou nd th e site of the a nti ge n c h all e n ge (Askenase ct 111 , 1983) . CD4 + T cell s are divided into two major SlIbpopulations accord in g to d iffe rences Ma nu script recc ivcd Decembe r · 14, 1995; rev ised May 29, 1996; accepted for publi cation Jun e 12. 1996.
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Ab breviations: C HR, contact hyperscnsitiv ity reaction; DLN, drainin g lymp h node; L-NAME. N G-ni tro-L-arginine methyl ester: NOS, ni tri c oxide synth ase: PCI, picryl chl orid e. L-arginine increased both early and late phase reactions. D-Arginine (enantiomer of L-arginine) did not increase the antigen-induced ear swelling. L-NAME injection, however, did not suppress phenol-induced irritant infiamlnation. TreatInent of mice undergoing PCI-induced contact hypersensitivity reaction with L-NAME reduced the production of interleukin-2 and interferon-y by draining lymph node cells.
Treatment with L-arginine, on the other hand, increased the production of interleukin-2 and interferon-I'. These results suggest that NO plays a modulating role in contact hypersensitivity reaction. Key "est De,.,,,atol 107:549-552, 1996 in lymph okin e produ c tion. Thc latc co mponent C HR T cell has been show n to belo n g to the Thl type, interleukin-2 (IL-2), and interfer o n-1' (IFN-I') produ cing CD4 + sub set (Che r and Mosmann, 1987).
l~cccntly, NO h as bee n impLicated in patho logica l co nd itions (Kolb a nd Ko lb-Bac h ofen. 1992, Koprowski et 111.1 993) , but p a rti cip atio n of NO in CHR is still obscure. In this study, we have in vestigated the ro lc of NO in PC I-induced CH l~ in mi ce. We find that a low do se of NOS inhibitor (1 mg/kg) redu ccd the early phase of CHR. but not the late pha sc reactio n, w hil e a high dose of NOS inhibitor (250 mg/ kg) redu ced both early-and late-phase l·ea ction s.
We h ave a lso in vestigated t h e rolc of NO in cy tokine produ c tion in this mode L MATE IUALS AND MET HODS Animals CllA /j fema le mice 6 to 8 wk old were obtaincd fr0111 C harles I~ver (Kanagawa , japan). The mice were rested at least 2 wk before usc. T hey we re housed in a temperature-controlled rOOI11 and received food and "vater ad libitulII, S ix 111i cc were llsed in each cx pcril11Clltal group , alld each cxpcrinll!nt \vas repeate d three ti n1 cs.
General Reagents 2.4 .6-Trini troch lorobenzcne (picryl chl oride, PCI) was obta in ed fr0111 Wako Pure C hem ica l. Inc. (Osaka. Jap",1) . NG-Ni tro-L-"rgininc methyl ester (L-NAM E) . its enantiomer. D-NAME, L-arginine (Arg) . and D-A rg we re obtained fi'o m Sigma (St Lo ui s, MO). Pheno l was obtnin ed from GIBCO 8RL (O ntnrio. Canada).
Contact Sensitization Mice were co ntnct sensitized by cutaneous topica l appl ication of150 pJ of 5% PC I in absolute etha nol and acctone (4:1) to the shavcd back ski n o n da y O.
Measurement of Ear Swelling Responses O n da y 4 th e mice were chall engcd by the topica l app li catio n of 1 0 p.l ofO.S'X, PC I to the left car. A constant area of the ea rs was l11 easured immediately before the challenge. 
(hr)
Hrs after Challenge at 2 and 24 h after pain tin g.
Trcatlncllt with L-NAME, D-NAME, L-Arg or D-Arg In some expe rim ents, animals were injected intravenously ,with 1 mg, 50 mg or 250 mg L-NA.ME, D-NAME. L-Arg or D-Arg per kg at the time of sensitization or chall enge. The doses of L-NAME and L-Arg were chosen from a previou s report (Garside er ai, 1992) . Sensitization and ch all enge with PCI were performed as mentioned above.
Gcncration and Mcasurctncnt of Cytokincs Draining lymph node cell s we re obtained 24 h after the PCI challenge or treatmen t with either L-NAME (250 mg/ kg) or L-Arg (250 mg/kg) at the time of the chall enge. The cell s were resuspended at 10 6 cell s/m l and di spensed (1 ml / well) in 24-well plates. C ultures were stim ul ated w ith 5 fLg co ncanavalin A(Con A) per ml and supern atants obta ined at 24 h post stimu lation. The levels of IL-2, interleukin 4 (IL-4), and IFN-y were mcasured by enzyme-linked immunosorbent assay kits, (Genzymc, Cambridge, MA) according to manufacturers' in structions. The cytokine content of each samp le was read off from a standard curve established with the approp riate recombinant cytokine.
Statistics Statistical sign ifi cance (p < 0.05) was ana lyzed by the Student's t test. H..esu lts are expressed as mean ± SO.
RESULTS
Changes with Time in CHR Ear swe lJing was measured at various time intervals of30 min, 1,2,3,4,24, and 48 h after CHR indu ction. As shown in Fig 1, car swellin g peaked at 2 and 24 h after CHR indu ction. Based on this finding, the m easure ments obtained at 2 and 24 h were rega rd ed as indi c ators of the ea rl y and the late ph ase of CHR, respectively. Treatment Effects at PCI Challenge PCl-induced ea rly phase ofCHR was inh ibited b y L-NAME (1 m g/kg, 50 mg/kg, and 250 mg/ kg) (Fig 2) . PCl-induced late phase ofCHR was inhibited only by high-dose L-NAME (250 m g/kg) (Fig 3) . D-NAME had no effect on e ith e r phase (Figs 2,3) . The ea rl y-phase C HR was in creased by L-Arg injected at doses of 50 mg/kg or 250 mg/kg , but no t 1 mg/kg. The late phase of C HR was in creased by a hi g h dose (250 mg/kg) but not by a lower dose ofL-Arg (Fig 3) . D-Arg (Table I) . Inj ection of L-NAME (250 mg/kg) at the time of PC l c h all enge led to a significant decrease in the produ c tion of these cytokines compared with PCl c haIJen ge without L-NAME treatment (p < 0.01 for lL-2 and I FN-y; Table I . . led to a significant increase in the prod uction of IL-2 and IFN-y by the lymph node cell s ill "ilm compared with PCI cha llenge w ithout L-Arg treatment (p < 0.05 for IL-2 an d for IFN-y; Table I ). IL-2
and INF-y levels in lymp h node cell cu ltures prepared 2 h afte r the challenge showed no significant change compared with animal s treated with ethanol acetone alone (data not show n) . IL-4 was not detec table in the sup ernatants of cells cultured with Con A in any gro up.
I L-NAME Does Not Suppress Phenol-Induced Irritant Infianllnation To examine whether L-NAME has a suppressive effect on nonimmunologic inflammation, we injected 250 mg/ kg , L-NAME or D-NAME intravenously at the time of the treatment with 20% phenol. Phenol induced ear swellin g at 2 h after painting, and ear swelling decreased 24 h after phenol painting. L-NAME did not suppress 2-h ear swelling . T he time course of the ear swelling • for mice treated with L-NAME showed a pattern similar to that of mice treated with D-NAME, indicating no effect of L-NAME on phenol-induced inflammation (Table II) .
DISCUSSION
N O is a labile humoral substance that acco unts for the activity of endothelium-derived relaxing factor and ca uses vasodilation by relaxing vascular smooth muscle by stimu lation of soluble g uanylate cyclase (Moncada et ai, 1989) . NO is rel eased from vascular e ndot~l.eliaJ cell s ill "itm in response ~o substances such as brady~ nin, histamll1e, or 5-hydroxytryptamme (Palmer et ai, 1987) . NO IS also fonned by macrophages activated by lipopolysaccharide (Lyons et ai, 1992) or cytokines (Kanno et ai, 1993) . NO has been implicated in pathologic conditions such as graft-verslls-host disease (Garside el ai, 1992) and neurologic diseases (Koprowski el ai , 1993) . Increasing evidence suggests that NO might playa role in acu te and chronic inflammation . Treatment with inhibitors of NOS reduce d, whereas L-Arg en hanced, the extent of the lesions both in a model of ac ute inflammation (I alenti et ai, 1992) and in adjuvant arthritis in rats (McCartney el ai, 1993 ) . In the current study, we examined the participation of NO in PCI-induced CHR in mice. At least two different cells separately mediate the early and late components ofCHR that respectively are accompanied by maximal ear swelling at 2 and 24 h after chall enge (Fig 1) . T he immediate hyperse nsitivity-like early phase component of CHR is due to the local release of vasoactive amine serotonin by mast cells (Van Loveren el ai, 1984) . The NOS inhibitor ca n reduce region al and microvasc ul ar blood flow and vascular permea bility (Whittle et ai, 1989 , Gardiner el ai, 1990 . The reg ulators of increased vascu lar permeabili ty and edema formation were induced by inflammatory events . Endogenous cNOS is involved in edema formation induced in the rat by substance P (Hughes el ai, 1990). cNOS generation can act to increase microvascular blood flow at the inflammatory site, leading to enh anced plasma extravasation and edema formation.
Thus, NO appears to be generated eithe r by the vascular endotheli al cell s, via cNOS stimulated by some inflammatory mediators (histamine, 5-hydroA}'tryptaminc, bradykinin), or by the induci ble e nzym e ca rri ed to the infl ammatory site by the infiltration of polymorphonuclear cell s or re leased by local tissues such as the vascu lar endothelium (Whittle et ai, 1989) . The findings that the ea rly phase of CHR was induced by vasodilation and vasopermeability to cells (Askenase ef ai, 1983) and that the low doses of NOS inhibitor (1 mg/kg) reduced the early phase of CHR suggest the possibility that this phase is m edi ated by vascular endotheliumderived cNOS. Murine CD4 + T cell s can be divided into two main subsets according to the cytokines they produce. Thl cell s produce IL-2 and IFN-y, which is known to induce NO production by murine macrophages (Stuehr and M arlettaet, 1987, Ding et ai, 1988) . The late phase of CHR is mediated by Th1 type CD4 + T cells (Cher and Mosmann, 1987) . In this model, lymph node cells produced significantly higher levels of IL-2 and IFN-y 24 h after the PCl chall enge than animals treated with ethanol acetone alone. A high dose of L-NAME inhibited the late phase of CHR and decreased production of IL-2 and IFN-y. L-Arg increased the late phase of CHR and created an increase in the production ofIL-2 and IFN-y. The increase in 24-h ear sw elling with L-Arg was significant, but only approximately 33%. These changes are statistically significant but do not indicate that NO has a major role in the pathogen esis of the classic 24-h allergic contact hyp ersensitivity ear-swelling response. It is more likely that the partial deficiency in til e 24-h response reflects inh.ibition of necessary ea rly events. A low dose of NOS inhibitor did not inhibit th e late-phase response, indicating the possibility that a low dose of L-NAME d id not reduce iNOS formation. Intravenous injection ofL-NAME and L-Arg at tll e time of th e PCI challenge modulated the CHR but had no effect when injected at th e time of PCI sensitization. This evidence indicates that NO may playa role in the efferent phase ofCHR but not in the afferent phase . T he lack of a suppressive effect by L-NAME on phenol-indu ced inflammation suggests that NO is not required for th e induction of irritant de rmatitis.
